Answers are grounded in this paper and cite their sources.
Randomized Clinical TrialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is primarily transmitted person-to-person through the aerosolization of droplets containing contaminated nasopharyngeal secretions. 1 Povidone iodine (PI) solutions at concentrations as low as 0.5% rapidly inactivate SARS-CoV-2 in vitro with contact times as short as 15 seconds. 2 We investigated whether nasopharyngeal application of PI could reduce the viral load of patients with nonsevere coronavirus disease 2019 (COVID-19) symptoms.
No takes yet. Share an insight, caveat, or question.
Guénézan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: